Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.

@article{Cavallin2015TerlipressinPA,
  title={Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.},
  author={Marta Cavallin and Patrick Sequeira Kamath and Manuela Merli and Silvano Fasolato and Pierluigi Toniutto and Francesco G. Salerno and Mauro Bernardi and Roberto Giulio Romanelli and Cosimo Colletta and F Oppenheimer Salinas and Antonio Di Giacomo and Lorenzo Ridola and Ezio Fornasiere and Paolo Caraceni and Filippo Morando and Salvatore Piano and Angelo Gatta and Paolo Angeli},
  journal={Hepatology},
  year={2015},
  volume={62 2},
  pages={567-74}
}
UNLABELLED Hepatorenal syndrome (HRS), a serious complication of cirrhosis, is associated with high mortality without treatment. Terlipressin with albumin is effective in the reversal of HRS. Where terlipressin is not available, as in the United States, midodrine and octreotide with albumin are used as an alternative treatment of HRS. The aim was to compare the effectiveness of terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of HRS in a randomized… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 26 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Similar Papers

Loading similar papers…